173 related articles for article (PubMed ID: 18498443)
1. Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium-calmodulin kinase II.
El-Mlili N; Rodrigo R; Naghizadeh B; Cauli O; Felipo V
J Neurochem; 2008 Aug; 106(3):1440-9. PubMed ID: 18498443
[TBL] [Abstract][Full Text] [Related]
2. Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum.
ElMlili N; Boix J; Ahabrach H; Rodrigo R; Errami M; Felipo V
J Neurochem; 2010 Feb; 112(4):1005-14. PubMed ID: 20002515
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Protein Kinase A Modulates Intracellular Calcium/Calmodulin-Dependent Protein Kinase II, Nitric Oxide Synthase, and the Glutamate-Nitric Oxide-cGMP Pathway in Cerebellum. Differential Effects in Hyperammonemia.
Cabrera-Pastor A; Llansola M; Felipo V
ACS Chem Neurosci; 2016 Dec; 7(12):1753-1759. PubMed ID: 27673574
[TBL] [Abstract][Full Text] [Related]
4. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure.
Rodrigo R; Erceg S; Rodriguez-Diaz J; Saez-Valero J; Piedrafita B; Suarez I; Felipo V
J Neurochem; 2007 Jul; 102(1):51-64. PubMed ID: 17286583
[TBL] [Abstract][Full Text] [Related]
5. Post-synaptic density-95 promotes calcium/calmodulin-dependent protein kinase II-mediated Ser847 phosphorylation of neuronal nitric oxide synthase.
Watanabe Y; Song T; Sugimoto K; Horii M; Araki N; Tokumitsu H; Tezuka T; Yamamoto T; Tokuda M
Biochem J; 2003 Jun; 372(Pt 2):465-71. PubMed ID: 12630910
[TBL] [Abstract][Full Text] [Related]
6. Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo.
González-Usano A; Cauli O; Agustí A; Felipo V
J Neurochem; 2013 Apr; 125(1):133-43. PubMed ID: 23227932
[TBL] [Abstract][Full Text] [Related]
7. Chronic exposure to ammonia induces isoform-selective alterations in the intracellular distribution and NMDA receptor-mediated translocation of protein kinase C in cerebellar neurons in culture.
Giordano G; Sanchez-Perez AM; Burgal M; Montoliu C; Costa LG; Felipo V
J Neurochem; 2005 Jan; 92(1):143-57. PubMed ID: 15606904
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia.
Zhou C; Li C; Yu HM; Zhang F; Han D; Zhang GY
J Neurosci Res; 2008 Oct; 86(13):2973-83. PubMed ID: 18512761
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptor 5, but not 1, modulates NMDA receptor-mediated activation of neuronal nitric oxide synthase.
Llansola M; Felipo V
Neurochem Int; 2010 Mar; 56(4):535-45. PubMed ID: 20043967
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of neuronal nitric oxide synthase at Ser847 by CaM-KII in the hippocampus of rat brain after transient forebrain ischemia.
Osuka K; Watanabe Y; Usuda N; Nakazawa A; Fukunaga K; Miyamoto E; Takayasu M; Tokuda M; Yoshida J
J Cereb Blood Flow Metab; 2002 Sep; 22(9):1098-106. PubMed ID: 12218415
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of neuronal nitric oxide synthase at Ser847 in the nucleus intermediolateralis after spinal cord injury in mice.
Osuka K; Watanabe Y; Usuda N; Atsuzawa K; Aoshima C; Yamauchi K; Takayasu M; Yoshida J
Neuroscience; 2007 Mar; 145(1):241-7. PubMed ID: 17258865
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex.
Cauli O; Mansouri MT; Agusti A; Felipo V
Gastroenterology; 2009 Apr; 136(4):1359-67, e1-2. PubMed ID: 19245864
[TBL] [Abstract][Full Text] [Related]
13. Roles of hippocampal nitric oxide and calcium/calmodulin-dependent protein kinase II in inhibitory avoidance learning in rats.
Tan SE
Behav Pharmacol; 2007 Feb; 18(1):29-38. PubMed ID: 17218795
[TBL] [Abstract][Full Text] [Related]
14. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Rodrigo R; Cauli O; Gomez-Pinedo U; Agusti A; Hernandez-Rabaza V; Garcia-Verdugo JM; Felipo V
Gastroenterology; 2010 Aug; 139(2):675-84. PubMed ID: 20303348
[TBL] [Abstract][Full Text] [Related]
15. Calcium/calmodulin-dependent protein kinase I inhibits neuronal nitric-oxide synthase activity through serine 741 phosphorylation.
Song T; Hatano N; Horii M; Tokumitsu H; Yamaguchi F; Tokuda M; Watanabe Y
FEBS Lett; 2004 Jul; 570(1-3):133-7. PubMed ID: 15251453
[TBL] [Abstract][Full Text] [Related]
16. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of chronic hyperammonemia on modulation of the glutamate-nitric oxide-cGMP pathway by metabotropic glutamate receptor 5 and low and high affinity AMPA receptors in cerebellum in vivo.
Cabrera-Pastor A; Llansola M; Reznikov V; Boix J; Felipo V
Neurochem Int; 2012 Jul; 61(1):63-71. PubMed ID: 22521775
[TBL] [Abstract][Full Text] [Related]
18. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
19. Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
Monfort P; Muñoz MD; Felipo V
J Neurochem; 2005 Aug; 94(4):934-42. PubMed ID: 16092938
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
